Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.
Luc Gagnon
Advertisement
Luc Gagnon, PhD, is vice-president of Vaccine Sciences at Nexelis.
Articles by Luc Gagnon
Advertisement
Latest Updated Articles
The Key Elements for Assay Transfer SuccessPublished: December 2nd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
2
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
3
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
4
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
5
